Scientific Sessions

 


The schedule below reflects the invited program only. The complete schedule, including the submitted program, will be available closer to the conference.

Plenary Sessions

10:30 - 11:15 a.m.

Association Welcome


Session: PL-01-01

11:15 - 11:45 a.m.

Understanding the Earliest Phases of Alzheimer’s Disease

Marilyn Albert
Johns Hopkins University School of Medicine, USA
Theme: Therapeutics
Session: PL-01-02

10:30 - 11 a.m.

To be Announced.


Theme: Therapeutics
Session: PL-02-01

11 - 11:30 a.m.

Alzheimer’s Disease Blood-Based Biomarkers and AD Control


SangYun Kim
Seoul National University, South Korea
Theme: Diagnosis and Prognosis
Session: PL-02-02

10:30 - 11 a.m.

To be Announced.


Theme: Basic and Translational Science
Session: PL-03-01

11 - 11:30 a.m.

Vascular and Metabolic Risk Factors of Dementing Disorders


Rachel Whitmer
University of California, Davis, USA
Theme: Public Health and Psychosocial
Session: PL-03-02

10:30 - 11 a.m.

Imaging Neurodegeneration With MRI: What Is New?


David Wolk
University of Pennsylvania Memory Center, USA
Theme: Diagnosis and Prognosis
Session: PL-04-01

11 - 11:30 a.m.

The Cellular Phase of Alzheimer’s Disease


Bart De Strooper
University College London, United Kingdom; University of Leuven, Belgium
Theme: Basic and Translational Science
Session: PL-04-02

10:30 - 11 a.m.

Microglia in Neurodegenerative Conditions


Marco Colonna
Washington University in St. Louis, USA
Theme: Basic and Translational Science
Session: PL-05-01

11:00 - 11:30 a.m.

Genetic Epidemiology of Dementia


Sudha Seshadri
The University of Texas Health Science Center at San Antonio, USA
Theme: Public Health & Psychosocial
Session: PL-05-02


Symposium Sessions

Sunday, July 14
  • Disparities in Access to Dementia Care and Prevention [S1-01]
    8 - 9:30 a.m.

    Theme: Public Health and Psychosocial

PRESENTATIONS

SPEAKERS


Dementia Prevention Programs in Urban and Regional Aboriginal Communities in Australia [S1-01-01]

Kylie Radford
University of New South Wales, Australia


Effects of Health Literacy on Access to Dementia Care [S1-01-02]

Jennifer Lingler
University of Pittsburgh, USA


Improving the Lives of People with Dementia - The OECD Perspective [S1-01-03]

Elina Suzuki
Organization for Economic Co-operation and Development, France


Dementia As Access Barrier in Palliative Care [S1-01-04]

Li Gang
University of Pittsburgh, USA


Sunday, July 14
  • “Rare Variants” And Their Role In Genetic Etiology And Disease [S1-02]
    8 - 9:30 a.m.

    Theme: Basic and Translational Science

PRESENTATIONS

SPEAKERS


Analysis of Predicted Loss-of-Function Variants in UK Biobank Identifies Variants Protective for Disease [S1-02-01]

To be announced.


Whole Genome Sequencing and Imputation in Isolated Populations Identify Genetic Associations with Medically-Relevant Complex Traits [S1-02-02]

To be announced.


Population-Specific Genetic Variation in Large Sequencing Data Sets: Why More Data Is Still Better [S1-02-03]

To be announced.


High-Throughput SNP-Seq to Identify Noncoding Functional SNPs [S1-02-04]

To be announced.


Monday, July 15
  • PET and CSF Markers of Neuroinflammation [S2-01]
    8 - 9:30 a.m.

    Theme: Diagnosis and Prognosis

PRESENTATIONS

SPEAKERS


PET Markers of Microglia [S2-01-01]

Robert Innis
National Institute of Mental Health, USA


PET Markers of Astrocytes [S2-01-02]

Elena Rodriguez-Vieitez
Karolinska Institute, Sweden


Neuroinflammation: CSF Perspective [S2-01-03]

To be announced.


Fluid Biomarkers of Neuroinflammation [S2-01-04]

Charlotte Teunissen
VU University Medical Center, Netherlands


Monday, July 15
  • Precision Medicine [S2-02]
    8 - 9:30 a.m.

    Theme: Therapeutics

PRESENTATIONS

SPEAKERS


Precision Medicine Model for Targeted NSAID Therapy in AD [S2-02-01]

Sid O'Bryant
University of North Texas Health Science Center, USA


PPAR-Gamma [S2-02-02]

Michael Heneka
German Center for Neurodegenerative Diseases (DZNE), Germany


Insulin-Resistant Sub-Typing [S2-02-03]

Suzanne Craft
Wake Forest School of Medicine, USA


Subtyping of Clinical Subjects through Exosome Analyses [S2-02-04]

Dimitrios Kapogiannis
National Institute on Aging/National Institutes of Health (NIA/NIH), USA


Tuesday, July 16
  • Overlapping AD Pathologies and their Influence on Disease Phenotypes [S3-01]
    8 - 9:30 a.m.

    Theme: Diagnosis and Prognosis

PRESENTATIONS

SPEAKERS


Alzheimer’s and Vascular Disease: Pathologic Perspective [S3-01-01]

Costantino Iadecola
Weill Cornell Medicine, USA


Alzheimer’s Disease and Subcortical Vascular Cognitive Impairment (SVCI): Biomarker Perspective [S3-01-02]

Duk Na
Samsung Medical Center, Korea, Republic of Korea (South)


Alzheimer’s and Lewy Body Disease: Pathologic Perspective [S3-01-03]

David Irwin
University of Pennsylvania, USA


Alzheimer’s and Lewy Body Disease: Biomarker Perspective [S3-01-04]

To be announced.


Tuesday, July 16
  • Responder Analyses Leading to Hypothesis Generation for Prospective Study Designs [S3-02]
    8 - 9:30 a.m.

    Theme: Therapeutics

PRESENTATIONS

SPEAKERS


Statistics [S3-02-01]

Suzanne Hendrix
Pentara Corporation, USA


Multi-Crossover Randomized Control Design Approaches Based on Analyses of Responder/Non-Responder Outcomes [S3-02-02]

Steven Arnold Massachusetts General Hospital, USA; Harvard Medical School, USA
To be announced.


To be announced. [S3-02-03]

To be announced.


To be announced. [S3-02-04]

Eric Siemers
Cogstate, Ltd., USA


Wednesday, July 17
  • National Dementia Registries: Quality Control and Recruitment of Research Participants [S4-01]
    8 - 9:30 a.m.

    Theme: Public Health and Psychosocial

PRESENTATIONS

SPEAKERS


The Brain Health Registry for Recruitment of Research Participants: 5 Year Experience [S4-01-01]

Michael Weiner
University of California, San Francisco, USA


The Dutch Brain Health Registry for Recruitment of Research Participants [S4-01-02]

Marissa Zwan
VU University Medical Center, Netherlands


Swedish Clinical Quality Registry for Dementia [S4-01-03]

Dorota Religa
Karolinska Institute, Sweden


Australian Clinical Quality Registry for Dementia [S4-01-04]

Stephanie Ward
Monash University, Australia


Thursday, July 18
  • Delirium in Dementia: A Translational Aspect [S5-01]
    8:30 - 10 a.m.

    Theme: Basic and Translational Science

PRESENTATIONS

SPEAKERS


Description and Impact of Delirium on Dementia [S5-01-01]

Daniel Davis
University College London, United Kingdom


Biomarkers in Delirium [S5-01-02]

To be announced.


Neurobiology of Delirium and Its Intersection with Dementia: Insights from Animal Models [S5-01-03]

Colm Cunningham
Trinity College Dublin, Ireland


Systemic Inflammation Signaling to the Brain [S5-01-04]

Roosmarijn Vandenbroucke
Ghent University, Belgium


Join the Conversation #AAIC19

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs